ABC transporters in cancer: more than just drug efflux pumps

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Multidrug transporter proteins are primarily recognized for mediating chemoresistance in cancer cells via drug efflux.
• Emerging evidence suggests these transporters have critical, yet underexplored, roles in fundamental aspects of tumor biology beyond their transport functions.

Purpose of the Study:

• To highlight the need for definitive studies to establish causal links between multidrug transporter functions and cancer biology.
• To emphasize the importance of understanding these transporters' precise roles in tumorigenesis and therapeutic outcomes for developing novel targeted cancer therapies.

Main Methods:

• Review and synthesis of existing correlative evidence on multidrug transporter functions in cancer.
• Identification of knowledge gaps requiring causal validation studies.

Main Results:

• Current evidence for the broader roles of multidrug transporters in tumor biology is largely correlative.
• Definitive studies are lacking to confirm the causal impact of these transporters on cancer progression and treatment sensitivity.

Conclusions:

• Multidrug transporters are implicated in cancer biology beyond their established role in drug efflux.
• Clarifying the causal roles of these transporters in tumorigenesis and treatment response is crucial for advancing targeted cancer therapies.